A beaten-down sector quietly being transformed by AI, a firm 'uniquely positioned' within the Trump administration, and much more.
The energy tail risk no one’s talking about, why a retail giant got double-downgraded, a candidate for the next IPO pop, and more.
This week in Street Sheet Research: a six-week market rally hits a wall amid AI fatigue, Datadog barks back with post-earnings upgrades, and the U.S. redraws its critical minerals map. Plus, what Polymarket’s long-awaited U.S. debut could mean for prediction markets everywhere.
Plus, our weekly report covers Nvidia’s quantum leap, a tech giant’s unsung 'second monopoly', and more.
Plus, an attractive opportunity amid a 'minefield for investors', a slew of price target hikes across the crypto sector, and more.
Plus, a biotech with 'potentially game-changing' trial results, the 'too far, too fast' rally you might still be betting on, and more.
Plus, who could win from OPEC’s latest production target hike, Baird’s pick for the “AI juggernaut for the information age”, and more.
Plus, why markets shrugged off news of the shutdown, sweeping pharmaceutical developments in DC, and dueling analyst calls on Apple
Our first-ever premium research report is here: a truly global macro shift, and two ways to play it.
A sudden development in the genetic-editing sector, another wild week for Nvidia, and much more.
A bold Nvidia investment that didn’t grab headlines, a paradigm shift for commodity markets, and more.
Fed cut odds shift, EchoStar–SpaceX deal, Nike/Dick’s calls, BofA downgrade, pharma pressure, streaming shakeup.